The group’s principle activities include designing, synthesized, validating and patented a new class of protease substrates for enzymatic activity determination in serum and cells. The group’s products include PhiPhiLux(R), GranToxiLux(TM), cathepsin D, and Elastolux(R). The group operates from United States.
